Promoting Physical Activity in People With Schizophrenia.
ProActiveS
Testing an Intervention to Increase Physical Activity in Schizophrenia: A Feasibility and Acceptability Study.
4 other identifiers
interventional
20
0 countries
N/A
Brief Summary
People with schizophrenia die approximately 20 years earlier than those in the general population, and this is mostly due to cardiovascular disease (CVD) and related poor physical health. The risk factors for CVD are significantly more prevalent in people with schizophrenia, but they are largely preventable by, for example, engaging in regular PA. Existing interventions to increase PA in schizophrenia are generally atheoretical and lack manualisation and appropriate evaluation, thus reducing their usefulness to clinical practice. Drawing on the MRC Guidelines for the development and evaluation of complex interventions, a 12-week intervention was developed and informed by a systematic review of the factors that influence PA in people with schizophrenia and a qualitative study exploring the barriers and motivators to PA (n=10). The feasibility and acceptability of the intervention was then investigated in an uncontrolled pilot study (n=20). The pilot study demonstrated that the intervention was both feasible and acceptable to people with schizophrenia. The retention rate was 90% (n=18), and reasons given for dropout were work commitments and other illness. Of the 18 who completed the intervention, 17 (94%) increased their weekly step count, 14 (78%) met current public health guidelines of 10,000 steps per day at some point during the 12 weeks, 10 (56%) experienced some weight loss, 12 (67%) took up an additional health promotion opportunity (e.g., improving diet, stopping smoking, joining a gym) and 13 (72%) took up another form of PA in addition to walking (e.g., swimming). Participants found the intervention enjoyable and thought it should be offered to everyone with schizophrenia. The intervention also proved to be feasible and acceptable to staff who referred patients to take part. Informal feedback from staff confirmed the need for such a service, particularly for those taking anti-psychotic medication, and indicated that, if it was to be implemented more widely, it would be a popular and useful resource.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable schizophrenia
Started Nov 2015
Shorter than P25 for not_applicable schizophrenia
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 24, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2016
CompletedFirst Submitted
Initial submission to the registry
March 27, 2018
CompletedFirst Posted
Study publicly available on registry
May 2, 2018
CompletedMay 2, 2018
April 1, 2018
9 months
March 27, 2018
May 1, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility and acceptability of the intervention.
Feasibility and acceptability of the intervention was evaluated using mixed-methods to explore recruitment, delivery, reasons for drop-out, participant feedback (positive and negative), and suggestions for improvement. This was quantitatively assessed by recording the number of eligible participants that agreed to participate and the number of participants that enrolled but dropped out. Participants were also asked to complete a feedback form, which contained space for free text, during the last session of the intervention.
Post intervention (12 weeks).
Secondary Outcomes (2)
Change in weekly step count.
At baseline and at intervention end point (12 weeks).
Change in activity levels.
Throughout the 12-week intervention.
Study Arms (1)
ProActiveS
EXPERIMENTALAs this was a feasibility study, all participants received the intervention.
Interventions
A 12-week behaviour change intervention, during which time participants met with the researcher weekly and used a pedometer to measure step count and completed an activity diary to monitor progress, set goals and plan how to cope with identified barriers.
Eligibility Criteria
You may qualify if:
- Diagnosis of schizophrenia or related disorder (e.g., schizoaffective disorder, psychosis)
- Living in the community
- Clinically stable for at least 8 weeks prior to intervention enrolment
- Ability to safely walk unaided
You may not qualify if:
- Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Edinburghlead
- NHS Lothiancollaborator
- Chief Scientist Office of the Scottish Governmentcollaborator
Related Publications (1)
McNamee L, Mead G, MacGillivray S, Lawrie SM. Schizophrenia, poor physical health and physical activity: evidence-based interventions are required to reduce major health inequalities. Br J Psychiatry. 2013 Sep;203(3):239-41. doi: 10.1192/bjp.bp.112.125070.
PMID: 24085733BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephen M Lawrie, MBChB,FRCPsych
University of Edinburgh
- PRINCIPAL INVESTIGATOR
Gillian E Mead, MBChB,FRCPEd
University of Edinburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2018
First Posted
May 2, 2018
Study Start
November 24, 2015
Primary Completion
August 31, 2016
Study Completion
August 31, 2016
Last Updated
May 2, 2018
Record last verified: 2018-04